Economist David C. Datelle says the pharmaceutical industry's prices have less to do with innovation than with corporate ...

Industry leaders in pharma and MedTech are urging the government to establish a structured funding framework for R&D ahead of ...

Peethaambaran Kunnathoor, Chennai Saturday, January 24, 2026, 08:00 Hrs [IST] ...

While 2025 was the year of disruption for Trump’s pharma policies, we expect 2026 to be the year of truth: will the US ...

Regeneron Pharmaceuticals, Inc. nears a key earnings report after a strong JPM Healthcare update. Click here to find out why ...

January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences ...

Chai Discovery, Noetik, and Boltz have entered multi-year pharma partnerships focused on models, not molecules, hinting at AI’s “infrastructure moment.” ...

Astellas' CEO said he doesn't want to make acquisitions simply to fill a revenue gap. Takeda is preparing for Trintellix's U.S. patent expiry with a round of layoffs. | Astellas CEO said he doesn't ...

The owner of GSK’s soon-to-be-vacant Rockville R&D campus is gearing up for a significant renovation. The goal: reposition ...

Ahead of Union Budget 2026, industry leaders call for a structured funding framework to boost innovation and research in India's pharma and MedTech sectors.

While there were outliers, Marston said a major chunk of the investments are concentrated in a few key hubs: Pennsylvania and ...

Council brings together leading global scientific and clinical experts in metabolic diseases to guide development of Nxera’s ...